Observational Study of Ketamine Infusions for the Treatment of Chronic Pain

Part of paid clinical trials in Stanford, California.

Sponsor
Theresa Lii
Study ID
NCT05477004
Status
Enrolling By Invitation

Conditions

  • Chronic Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ketamine — DRUG
    A multi-day continuous ketamine infusion delivered intravenously at subanesthetic doses in a monitored setting

Study Details

This observational study will collect prospectively specified data on patient characteristics and clinically relevant outcomes in patients who receive a ketamine infusion at Stanford Pain Management Center for the treatment of chronic pain, with the goal of identifying treatment responders and relationships between patient characteristics and treatment response.

Key Dates

Start date
Jun 1, 2022
Status verified
Dec 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Open label ketamine
    Patients who receive a ketamine infusion for the treatment of chronic pain in the course of usual clinical care

Primary Outcome Measure

Change from baseline Patient Global Impression of Change (PGIC) in overall status; measured with PGIC Scale [ Time Frame: 1 week, 2 weeks, 1 month, 2 months, 3 months, 6 months, 12 months (or up to the time of their next ketamine infusion) ]

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford UniversityStanfordCalifornia94305-

Find similar trials in Stanford, CA

By research site
Stanford University· Stanford, CA

Related Studies